The Eyes Have It: Ocular Therapeutix Joins IPO Class Of 2014
Executive Summary
Ophthalmology has been one of the most active sectors in this year’s IPO boom. Joining the fray in late July: Ocular Therapeutix, which is developing sustained-release formulations of existing ophthalmic drugs.